Results 1 to 10 of about 157,141 (260)

Systemic pre-conditioning favors effector over exhausted CD8 T-cell subsets following Sup2-IL33 armored CAR T-cell therapy. [PDF]

J Immunother Cancer
Ferry SL, Abdullah L, Balasubramanian A, Nowak EC, Carl A, Turnquist A, Mohamed A, Usherwood E, Sundrud M, Huang Y.   +9 more
europepmc   +1 more source

The T Cell Receptor: Molecular Sensor, Therapeutic Mediator and Probabilistic Driver of Adaptive Immunity. [PDF]

Immunol Rev
Schober K.
europepmc   +1 more source

Engineering functionality-optimized fully human B7-H3 CAR T cells for enhanced solid tumor therapy. [PDF]

Cell Rep Med
Bajgain P, Feng Y, Puebla M, Tian M, Hsu KS, Lee J, Yu G, Yang L, Seaman S, Hilton MB, Morris K, Borchin N, Tran JD, Metcalfe RD, Li D, Ho M, Cronk JC, Khan J, Nellan A, Kaplan RN, St Croix B.   +20 more
europepmc   +1 more source

Mania and psychosis following chimeric antigen receptor T-cell therapy: A report of two cases and mechanistic discussion. [PDF]

Brain Behav Immun Health
Stollenwerk TM, Barnett ME, Steineck AS, Shah NN, Knight JM.   +4 more
europepmc   +1 more source

Noise-induced instability of uniform flow in single-file traffic systems. [PDF]

PNAS Nexus
Dufour O, Nicolas A, Rodney D, Cordes J, Schadschneider A, Tordeux A.   +5 more
europepmc   +1 more source

CAR-T cells directed toward PD-L1 demonstrate potent, antigen-specific activity against cholangiocarcinoma: A proof of concept study. [PDF]

Mol Ther Oncol
Gondaliya P, Luo Y, Sayyed AA, Zinn DA, Qie Y, Yan IK, Driscoll J, Patel PB, Li S, Qin H, Patel T.   +10 more
europepmc   +1 more source

Human CART22.19 therapy in refractory pediatric B-ALL: insights from a named-patient cohort. [PDF]

J Immunother Cancer
Mast AS, Lang P, Schlegel P, Calkoen FG, Atar D, Scheuermann S, Klein S, Braun C, Schinle F, Schmidt M, Hensen L, Ebinger M, Döring M, Schäfer JF, Schulte J, Bethge WA, Lengerke C, Alahmari B, Hu P, Schneider D, Orentas RJ, Handgretinger R, Seitz CM.   +22 more
europepmc   +1 more source

Impact of Glycine-Serine Linker on Target Antigen Binding and Subsequent CD37CAR-T Performance. [PDF]

Int J Mol Sci
Khopanlert W, Prompat N, Saetang J, Maneechai K, Okuno S, Terakura S, Julamanee J.   +6 more
europepmc   +1 more source